Abbreviations: BSA, bovine serum albumin; [Ca 2+ ] i , intracellular free Ca A c c e p t e d M a n u s c r i p t 5 ABSTRACT Sphingosine-1-phosphate (S1P) acts as high affinity agonist at specific G-protein-coupled receptors, S1P [1][2][3][4][5] , that play important roles e.g. in the cardiovascular and immune systems. A S1P receptor modulating drug, FTY720 (fingolimod), has been effective in phase III clinical trials for multiple sclerosis. FTY720 is a sphingosine analogue and prodrug of FTY720-phosphate, which activates all S1P receptors except S1P 2 and disrupts lymphocyte trafficking by internalizing the S1P 1 receptor. Cis-4-methylsphingosine (cis-4M-Sph) is another synthetic sphingosine analogue that is readily taken up by cells and phosphorylated to cis-4-methylsphingosine-1-phosphate (cis-4M-S1P). Therefore, we analysed whether cis-4M-Sph interacted with S1P receptors through its metabolite cis-4M-S1P in a manner similar to FTY720. Indeed, cis-4M-Sph caused an internalization of S1P receptors, but differed from FTY720 as it acted on S1P 2 and S1P 3 and only weakly on S1P 1 , while FTY720 internalized S1P 1 and S1P 3 but not S1P 2 . Consequently, pre-incubation with cis-4M-Sph specifically desensitized S1P-induced [Ca 2+ ] i increases, which are mediated by S1P 2 and S1P 3 , in a timeand concentration-dependent manner. This effect was not shared by sphingosine or FTY720, indicating that metabolic stability and targeting of S1P 2 receptors were important. The desensitization of S1P-induced [Ca 2+ ] i increases was dependent on the expression of SphKs, predominantly of SphK2, and thus mediated by cis-4M-S1P. In agreement, cis-4M-S1P was detected in the supernatants of cells exposed to cis-4M-Sph. It is concluded that cis-4M-Sph, through its metabolite cis-4M-S1P, acts as a S1P receptor modulator and causes S1P receptor internalization and desensitization. The data furthermore help to define requirements for sphingosine kinase substrates as S1P receptor modulating prodrugs.